Pierre Michel
Unité d'oncologie digestive
Service d'Hepato-Gastroenterologie
CHU de Rouen
1 rue de Germont 76031 Rouen Cedex
France
Name/email consistency: high
- Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Michel, P., Adenis, A., Di Fiore, F., Boucher, E., Galais, M.P., Dahan, L., Mirabel, X., Hamidou, H., Raoul, J.L., Jacob, J.H., Hellot, M.F., Prod'homme, S., Paillot, B. Br. J. Cancer (2006)
- Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?. Michel, P., Roque, I., Di Fiore, F., Langlois, S., Scotte, M., Tenière, P., Paillot, B. Gastroenterol. Clin. Biol. (2004)
- Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. Michel, P., Magois, K., Robert, V., Chiron, A., Lepessot, F., Bodenant, C., Roque, I., Seng, S.K., Frebourg, T., Paillot, B. Int. J. Radiat. Oncol. Biol. Phys. (2002)
- Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance. Michel, P., Paresy, M., Lepessot, F., Hellot, M.F., Paillot, B., Scotte, M., Peillon, C., Ducrotté, P., Hemet, J. Eur. J. Gastroenterol. Hepatol (2000)
- Postoperative management of stage II/III colon cancer: a decision analysis. Michel, P., Merle, V., Chiron, A., Ducrotte, P., Paillot, B., Hecketsweiler, P., Czernichow, P., Colin, R. Gastroenterology (1999)